EPRX Competitors & Alternatives
Compare Eupraxia Pharmaceuticals Inc. Common Stock with similar stocks in the same industry
Biotechnology
EPRX
Main Stock$8.40
Tradestie Score
31
Market Cap
$307.12M
Analyst Upside
+94.6%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$12.40
|
$529.35M | 13.5 | 42 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$117.56
|
$522.78M | - | 49 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.24
|
$512.39M | - | 65 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$48.67
|
$505.12M | 2.9 | 37 | Compare |
|
RGNX
REGENXBIO Inc.
|
$8.94
|
$493.52M | - | 47 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$121.17
|
$492.21M | - | 34 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$8.82
|
$468.01M | - | 39 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$13.84
|
$463.20M | - | 63 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$10.25
|
$457.09M | - | 31 | Compare |
More EPRX Analysis
Data updated: Sep 07, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry